Introduction
Although hyperlactatemia is common after cardiac surgery (CS), its value and utility as a prognostic marker is controversial.
Objectives
The aim of the present study was to determine whether postoperative serial arterial lactate (AL) measurements after CS can predict outcome.
Methods
Prospective, observational study in our Surgical ICU in a tertiary-level university hospital. AL was measured on ICU admission,6,12 and 24h after CS, together with clinical data and outcomes including in-hospital and long-term mortality.
Results 2935 patients were included. In-hospital and long-term mortality (mean follow-up 6.3 ± 1.7 years) were 5.9% and 8.3% respectively.In comparison with survivors, non-survivors showed higher mean AL values in all measurements (P < 0.001). Hyperlactatemia (AL>3.0 mmol/L) was a predictor for both in-hospital mortality (OR:1.468; 95% CI:1.239-1.739; P < 0.001) and longterm mortality(HR:1.511; 95% CI:1.251-1.825; P < 0.001). Recent myocardial infarction and longer cardiopulmonary bypass time were predictors of hyperlactatemia. The pattern of AL dynamics was similar in both groups, but non-survivors presented higher AL values, as confirmed by repeated measures analysis of variance (P < 0.001).
The area under the curve also showed higher levels of AL in non-survivors(80.9 ± 68.2 vs. 49.71 ± 25.8 mmol·L 
Conclusions
The dynamics of the postoperative AL curve in patients undergoing cardiac surgery suggests a similar mechanism of hyperlactatemia in both groups,albeit with a higher production or lower clearance of AL in non-survivors. The presence of a peak of hyperlactatemia at 24h is associated with higher in-hospital and long-term mortality in those patients.
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